Oxidative Stress and Pyroptosis Mediated by CEBPB/HMGB1 Signaling in Sepsis-Exacerbated Coronary Atherosclerosis

Shuyao Zhang1, Wei He1, Xinyue Lin2

  • 1Department of Pharmacy, Guangzhou Red Cross Hospital, (Guangzhou Red Cross Hospital of Jinan University), Guangzhou, People's Republic of China.

PubMed

Insights

This study reveals the CEBPB/HMGB1/VCAM1 axis drives oxidative stress and vascular damage in sepsis-exacerbated coronary artery disease (CAD). Targeting this pathway offers new strategies for preventing cardiovascular complications.

Area of Science:

  • Cardiovascular Biology
  • Inflammation and Immunology
  • Oxidative Stress Research

Background:

  • Sepsis can worsen pre-existing coronary artery disease (CAD).
  • Oxidative stress and specific inflammatory pathways are implicated in this exacerbation.
  • The CEBPB/HMGB1/VCAM1 signaling axis's role in sepsis-induced CAD is not fully understood.

Purpose of the Study:

  • To investigate the CEBPB/HMGB1/VCAM1 signaling axis in sepsis-exacerbated CAD.
  • To elucidate the mechanisms linking systemic inflammation, oxidative stress, and vascular damage.
  • To identify potential therapeutic targets for cardiovascular complications of sepsis.

Main Methods:

  • Established a sepsis-exacerbated CAD mouse model (cecal ligation and puncture + high-fat diet).
  • Utilized lentiviral vectors for gene manipulation (CEBPB, VCAM1) in vivo and in vitro.
  • Employed single-cell RNA sequencing, transcriptomics, ChIP, luciferase assays, ELISA, ROS detection, and flow cytometry.

Main Results:

  • Sepsis upregulated CEBPB in macrophages, promoting HMGB1 transcription, pyroptosis, and ROS production.
  • HMGB1 released from macrophages increased endothelial cell (EC) VCAM1 expression via NF-κB, causing endothelial dysfunction.
  • Targeting HMGB1 or VCAM1 alleviated EC damage in vitro and modulated inflammatory markers in vivo.

Conclusions:

  • The CEBPB/HMGB1/VCAM1 axis is a key mediator linking sepsis-induced inflammation to oxidative vascular damage in CAD.
  • This pathway represents a novel therapeutic target for managing sepsis-related cardiovascular complications.
  • Findings offer insights for preventing cardiovascular issues in sepsis patients.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
359
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
340
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
772
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
19.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K